MET
Price
$80.98
Change
-$1.83 (-2.21%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
52.66B
63 days until earnings call
Intraday BUY SELL Signals
SNFCA
Price
$9.23
Change
-$0.32 (-3.35%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
248.66M
Intraday BUY SELL Signals
Interact to see
Advertisement

MET vs SNFCA

Header iconMET vs SNFCA Comparison
Open Charts MET vs SNFCABanner chart's image
MET vs SNFCA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MET vs. SNFCA commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MET is a Hold and SNFCA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (MET: $82.82 vs. SNFCA: $9.55)
Brand notoriety: MET: Notable vs. SNFCA: Not notable
Both companies represent the Life/Health Insurance industry
Current volume relative to the 65-day Moving Average: MET: 95% vs. SNFCA: 84%
Market capitalization -- MET: $52.66B vs. SNFCA: $248.66M
MET [@Life/Health Insurance] is valued at $52.66B. SNFCA’s [@Life/Health Insurance] market capitalization is $248.66M. The market cap for tickers in the [@Life/Health Insurance] industry ranges from $154.94B to $0. The average market capitalization across the [@Life/Health Insurance] industry is $17.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MET’s FA Score shows that 3 FA rating(s) are green whileSNFCA’s FA Score has 0 green FA rating(s).

  • MET’s FA Score: 3 green, 2 red.
  • SNFCA’s FA Score: 0 green, 5 red.
According to our system of comparison, MET is a better buy in the long-term than SNFCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MET’s TA Score shows that 3 TA indicator(s) are bullish while SNFCA’s TA Score has 4 bullish TA indicator(s).

  • MET’s TA Score: 3 bullish, 5 bearish.
  • SNFCA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SNFCA is a better buy in the short-term than MET.

Price Growth

MET (@Life/Health Insurance) experienced а -0.54% price change this week, while SNFCA (@Life/Health Insurance) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Life/Health Insurance industry was -3.38%. For the same industry, the average monthly price growth was -4.09%, and the average quarterly price growth was +0.80%.

Reported Earning Dates

MET is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Life/Health Insurance (-3.38% weekly)

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MET($52.7B) has a higher market cap than SNFCA($249M). MET has higher P/E ratio than SNFCA: MET (16.02) vs SNFCA (7.21). MET YTD gains are higher at: 6.475 vs. SNFCA (5.993). SNFCA has less debt than MET: SNFCA (123M) vs MET (20.2B). MET has higher revenues than SNFCA: MET (76B) vs SNFCA (342M).
METSNFCAMET / SNFCA
Capitalization52.7B249M21,165%
EBITDAN/AN/A-
Gain YTD6.4755.993108%
P/E Ratio16.027.21222%
Revenue76B342M22,222%
Total CashN/A128M-
Total Debt20.2B123M16,423%
FUNDAMENTALS RATINGS
MET vs SNFCA: Fundamental Ratings
MET
SNFCA
OUTLOOK RATING
1..100
7634
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
4464
SMR RATING
1..100
9586
PRICE GROWTH RATING
1..100
3257
P/E GROWTH RATING
1..100
3078
SEASONALITY SCORE
1..100
3550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MET's Valuation (30) in the Life Or Health Insurance industry is in the same range as SNFCA (47). This means that MET’s stock grew similarly to SNFCA’s over the last 12 months.

MET's Profit vs Risk Rating (44) in the Life Or Health Insurance industry is in the same range as SNFCA (64). This means that MET’s stock grew similarly to SNFCA’s over the last 12 months.

SNFCA's SMR Rating (86) in the Life Or Health Insurance industry is in the same range as MET (95). This means that SNFCA’s stock grew similarly to MET’s over the last 12 months.

MET's Price Growth Rating (32) in the Life Or Health Insurance industry is in the same range as SNFCA (57). This means that MET’s stock grew similarly to SNFCA’s over the last 12 months.

MET's P/E Growth Rating (30) in the Life Or Health Insurance industry is somewhat better than the same rating for SNFCA (78). This means that MET’s stock grew somewhat faster than SNFCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
METSNFCA
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 14 days ago
62%
Bullish Trend 6 days ago
65%
Declines
ODDS (%)
Bearish Trend 7 days ago
55%
Bearish Trend 24 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
62%
Aroon
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
MET
Daily Signal:
Gain/Loss:
SNFCA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GWW1268.3625.33
+2.04%
WW Grainger
SMPL11.810.15
+1.24%
Simply Good Foods Company (The)
TLF2.36N/A
N/A
Tandy Leather Factory
VYGR3.60-0.20
-5.15%
Voyager Therapeutics
NTSK12.10-0.76
-5.91%
Netskope Inc.

MET and

Correlation & Price change

A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
+1.20%
PRU - MET
74%
Closely correlated
+2.22%
LNC - MET
71%
Closely correlated
+0.78%
CNO - MET
67%
Closely correlated
+1.91%
JXN - MET
64%
Loosely correlated
+1.80%
MFC - MET
61%
Loosely correlated
+2.02%
More